Demonstrates how microRNA-383-5p reduces hemorrhagic transformation in stroke, suggesting a new protective target.
Background: Hemorrhage transformation (HT) following endovascular reperfusion treatment is associated with poor clinical outcomes in acute ischemic stroke patients. MicroRNAs modulate several aspects of cerebral ischemia-reperfusion injury, including blood-brain barrier (BBB) integrity, inflammation, oxidative stress, and apoptosis, significantly impacting cerebral recovery and function. This study investigated the role of microRNA-383 in HT in the oxygen-glucose deprivation reoxygenation (OGD/R) model of neurons and the transient middle cerebral artery occlusion (MCAO) model. Methods: The isoforms of 5p and 3p of miR-383, the family of nicotinamide adenine dinucleotide phosphate oxidase (NOX), peroxiredoxin (PRDX), toll-like receptor, and caspase expression in the OGD/R mice neuron model were assessed. The neuronal injury, neuronal apoptosis, the expression of reactive oxygen species (ROS), and the regulation of miR-383-5p target genes were evaluated after the miR-383-5p and small interfering RNA intervention. A mechanical reperfusion-induced HT model was established in hyperglycemic rats using 5-hour MCAO followed by 3 hours and 6 hours of reperfusion. MiR-383-5p agomir was administered intravenously before reperfusion. Infarct volume, brain water content, HT, neurological score, BBB damage, neuronal apoptosis, ROS, the expression of miR-383-5p and its target genes, and BBB-associated proteins were evaluated. Results: MiR-383-5p expression significantly decreased in OGD/R-treated neurons, while miR-383-3p expression did not differ. The expression of NOX2, NOX3, NOX4, PRDX1, PRDX3, PRDX4, PRDX5, and PRDX6 increased in neurons after OGD/R. Elevating miR-383-5p levels reduced neuronal injury, neuronal apoptosis, ROS expression, and suppressed the expression of its direct target genes, NOX4 and PRDX3, in the OGD/R model. Intravenous administration of miR-383-5p agomir increased the expression of miR-383-5p, suppressed the upregulation of NOX4 and PRDX3, and reduced infarct volume, brain edema, reperfusion-induced HT, BBB breakdown, neuronal apoptosis, and ROS after ischemia, improving neurological outcomes in the MCAO model. Conclusions: MiR-383-5p alleviates neuronal injury, oxidative stress, and apoptosis in neurons subjected to ischemia-reperfusion injury by regulating NOX4 and PRDX3. Neuronal miR-383-5p may be a protective target for reducing hemorrhagic transformation and improving outcomes following mechanical reperfusion in acute ischemic stroke.
No takes yet. Share an insight, caveat, or question.
Shi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: